was read the article
array:22 [ "pii" => "S0001731014700146" "issn" => "00017310" "doi" => "10.1016/S0001-7310(14)70014-6" "estado" => "S300" "fechaPublicacion" => "2014-10-01" "aid" => "70014" "copyright" => "Academia Española de Dermatología y Venereología" "copyrightAnyo" => "2014" "documento" => "article" "subdocumento" => "fla" "cita" => "Actas Dermosifiliogr. 2014;105 Supl 1:9-20" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1123 "formatos" => array:3 [ "EPUB" => 36 "HTML" => 327 "PDF" => 760 ] ] "itemSiguiente" => array:17 [ "pii" => "S0001731014700158" "issn" => "00017310" "doi" => "10.1016/S0001-7310(14)70015-8" "estado" => "S300" "fechaPublicacion" => "2014-10-01" "aid" => "70015" "copyright" => "Academia Española de Dermatología y Venereología" "documento" => "article" "subdocumento" => "fla" "cita" => "Actas Dermosifiliogr. 2014;105 Supl 1:21-33" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 770 "formatos" => array:3 [ "EPUB" => 32 "HTML" => 273 "PDF" => 465 ] ] "en" => array:10 [ "idiomaDefecto" => true "titulo" => "IL-17 and IL-17R: an auspicious therapeutic target for psoriatic disease" "tienePdf" => "en" "tieneTextoCompleto" => 0 "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "21" "paginaFinal" => "33" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "IL-17 e IL-17R: una diana terapéutica favorable para la enfermedad psoriásica" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "A. Mitra, S.K. Raychaudhuri, S.P. Raychaudhuri" "autores" => array:3 [ 0 => array:2 [ "nombre" => "A." "apellidos" => "Mitra" ] 1 => array:2 [ "nombre" => "S.K." "apellidos" => "Raychaudhuri" ] 2 => array:2 [ "nombre" => "S.P." "apellidos" => "Raychaudhuri" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731014700158?idApp=UINPBA000044" "url" => "/00017310/00000105000000S1/v1_201411120051/S0001731014700158/v1_201411120051/en/main.assets" ] "itemAnterior" => array:17 [ "pii" => "S0001731014700134" "issn" => "00017310" "doi" => "10.1016/S0001-7310(14)70013-4" "estado" => "S300" "fechaPublicacion" => "2014-10-01" "aid" => "70013" "copyright" => "Academia Española de Dermatología y Venereología" "documento" => "simple-article" "subdocumento" => "edi" "cita" => "Actas Dermosifiliogr. 2014;105 Supl 1:6-8" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 460 "formatos" => array:3 [ "EPUB" => 28 "HTML" => 245 "PDF" => 187 ] ] "en" => array:7 [ "idiomaDefecto" => true "titulo" => "IL-17 in psoriasis. The final frontier or just another brick in the wall?" "tienePdf" => "en" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "6" "paginaFinal" => "8" ] ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "J.M. Carrascosa, L. Puig" "autores" => array:2 [ 0 => array:2 [ "nombre" => "J.M." "apellidos" => "Carrascosa" ] 1 => array:2 [ "nombre" => "L." "apellidos" => "Puig" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731014700134?idApp=UINPBA000044" "url" => "/00017310/00000105000000S1/v1_201411120051/S0001731014700134/v1_201411120051/en/main.assets" ] "en" => array:11 [ "idiomaDefecto" => true "titulo" => "Pathogenic role of IL-17 in psoriasis and psoriatic arthritis" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "9" "paginaFinal" => "20" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "A. Chiricozzi" "autores" => array:1 [ 0 => array:2 [ "nombre" => "A." "apellidos" => "Chiricozzi" ] ] "afiliaciones" => array:2 [ 0 => array:2 [ "entidad" => "Department of Dermatology, University of Rome Tor Vergata, Rome, Italy" "identificador" => "aff0005" ] 1 => array:2 [ "entidad" => "Laboratory for Investigative Dermatology, The Rockefeller University, New York, USA" "identificador" => "aff0010" ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Papel patógeno de la IL-17 en la psoriasis y en la artritis psoriásica" ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec360878" "palabras" => array:8 [ 0 => "IL-17" 1 => "Psoriasis" 2 => "Arthritis" 3 => "Secukinumab" 4 => "Ixekizumab" 5 => "Brodalumab" 6 => "Atherosclerosis" 7 => "Obesity" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec360879" "palabras" => array:8 [ 0 => "IL-17" 1 => "Psoriasis" 2 => "Artritis" 3 => "Secukinumab" 4 => "Ixekizumab" 5 => "Brodalumab" 6 => "Aterosclerosis" 7 => "Obesidad" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:2 [ "titulo" => "Abstract" "resumen" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Psoriasis is a chronic inflammatory skin disorder resulting from a complex network of cytokines and chemokines produced by various immune cell types and tissue cells. Emerging evidence suggests a central role of IL-17 and IL-23/T17 axis in the pathogenesis of psoriasis, giving a rationale for using IL-17-blocking agents as therapeutics.</p><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Three agents targeting IL-17 signaling are being studied in Phase III clinical trials: secukinumab and ixekizumab (IL-17 neutralizing agents), and brodalumab (IL-17 receptor antagonist). Preliminary results are highly promising for all anti-IL17 agents, creating fair expectations on this class of agents as the new effective therapeutic approach for the treatment of psoriasis.</p>" ] "es" => array:2 [ "titulo" => "Resumen" "resumen" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">La psoriasis es un trastorno crónico inflamatorio de la piel resultante de un complejo sistema de citocinas y quimiocinas producidas por varios tipos de células inmunes y células tisulares. La evidencia incipiente sugiere un papel central de la IL-17 y el eje IL-23/T17 en la patogénesis de la psoriasis, lo que ofrece una base para el uso de agentes bloqueadores de la IL-17 como tratamiento.</p><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Están siendo estudiados en estudios clínicos en fase III tres agentes enfocados en la señalización de la IL-17: secukinumab e ixekizumab (agentes neutralizantes de la IL-17), y brodalumab (antagonista del receptor de la IL-17). Los resultados preliminares son altamente prometedores para todos los agentes anti-IL17, lo que crea claras expectativas para esta clase de agentes como un nuevo planteamiento terapéutico eficaz para el tratamiento de la psoriasis.</p>" ] ] ] "idiomaDefecto" => "en" "url" => "/00017310/00000105000000S1/v1_201411120051/S0001731014700146/v1_201411120051/en/main.assets" "Apartado" => array:4 [ "identificador" => "6148" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Editorial" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/00017310/00000105000000S1/v1_201411120051/S0001731014700146/v1_201411120051/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731014700146?idApp=UINPBA000044" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 4 | 4 | 8 |
2024 October | 44 | 45 | 89 |
2024 September | 38 | 36 | 74 |
2024 August | 67 | 75 | 142 |
2024 July | 47 | 32 | 79 |
2024 June | 66 | 61 | 127 |
2024 May | 38 | 40 | 78 |
2024 April | 38 | 52 | 90 |
2024 March | 43 | 36 | 79 |
2024 February | 32 | 42 | 74 |
2024 January | 24 | 35 | 59 |
2023 December | 42 | 40 | 82 |
2023 November | 35 | 44 | 79 |
2023 October | 29 | 25 | 54 |
2023 September | 46 | 33 | 79 |
2023 August | 21 | 19 | 40 |
2023 July | 33 | 42 | 75 |
2023 June | 32 | 20 | 52 |
2023 May | 47 | 34 | 81 |
2023 April | 33 | 38 | 71 |
2023 March | 22 | 38 | 60 |
2023 February | 26 | 25 | 51 |
2023 January | 25 | 25 | 50 |
2022 December | 35 | 22 | 57 |
2022 November | 26 | 20 | 46 |
2022 October | 33 | 13 | 46 |
2022 September | 25 | 35 | 60 |
2022 August | 39 | 28 | 67 |
2022 July | 29 | 34 | 63 |
2022 June | 20 | 24 | 44 |
2022 May | 41 | 45 | 86 |
2022 April | 43 | 23 | 66 |
2022 March | 49 | 57 | 106 |
2022 February | 26 | 28 | 54 |
2022 January | 40 | 51 | 91 |
2021 December | 38 | 53 | 91 |
2021 November | 28 | 43 | 71 |
2021 October | 32 | 46 | 78 |
2021 September | 34 | 49 | 83 |
2021 August | 19 | 27 | 46 |
2021 July | 43 | 47 | 90 |
2021 June | 26 | 42 | 68 |
2021 May | 31 | 55 | 86 |
2021 April | 89 | 84 | 173 |
2021 March | 50 | 44 | 94 |
2021 February | 24 | 30 | 54 |
2021 January | 29 | 18 | 47 |
2020 December | 33 | 26 | 59 |
2020 November | 30 | 29 | 59 |
2020 October | 18 | 19 | 37 |
2020 September | 29 | 25 | 54 |
2020 August | 38 | 42 | 80 |
2020 July | 37 | 26 | 63 |
2020 June | 42 | 42 | 84 |
2020 May | 47 | 35 | 82 |
2020 April | 52 | 35 | 87 |
2020 March | 54 | 22 | 76 |
2020 February | 6 | 1 | 7 |
2019 December | 0 | 2 | 2 |
2019 February | 0 | 2 | 2 |
2018 December | 0 | 2 | 2 |
2018 September | 0 | 2 | 2 |
2018 April | 0 | 3 | 3 |
2018 March | 2 | 5 | 7 |
2018 February | 14 | 34 | 48 |
2018 January | 24 | 24 | 48 |
2017 December | 14 | 23 | 37 |
2017 November | 32 | 30 | 62 |
2017 October | 19 | 27 | 46 |
2017 September | 13 | 27 | 40 |
2017 August | 11 | 17 | 28 |
2017 July | 19 | 35 | 54 |
2017 June | 22 | 24 | 46 |
2017 May | 19 | 29 | 48 |
2017 April | 15 | 40 | 55 |
2017 March | 20 | 48 | 68 |
2017 February | 10 | 24 | 34 |
2017 January | 12 | 47 | 59 |
2016 December | 11 | 20 | 31 |
2016 November | 24 | 27 | 51 |
2016 October | 26 | 37 | 63 |
2016 September | 0 | 2 | 2 |
2016 July | 4 | 14 | 18 |
2016 June | 0 | 13 | 13 |
2016 May | 0 | 6 | 6 |
2016 April | 0 | 10 | 10 |
2016 March | 0 | 15 | 15 |
2016 February | 0 | 19 | 19 |
2016 January | 0 | 16 | 16 |
2015 December | 0 | 7 | 7 |
2015 November | 0 | 28 | 28 |
2015 October | 0 | 21 | 21 |
2015 September | 0 | 34 | 34 |
2015 August | 0 | 25 | 25 |
2015 July | 0 | 1 | 1 |
2015 June | 0 | 8 | 8 |
2015 May | 0 | 3 | 3 |
2015 April | 1 | 2 | 3 |
2015 March | 2 | 5 | 7 |
2015 February | 7 | 1 | 8 |
2015 January | 2 | 1 | 3 |
2014 December | 2 | 0 | 2 |
2014 November | 2 | 0 | 2 |